Rating History for Mereo BipPharma Group (MREO) by JPMorgan
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/18/2026 | Priyanka Grover | Downgrade | Underweight (Neutral) |
N/A (N/A) |
0.31 (0.28) |
-9.68% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/18/2026 | Priyanka Grover | Downgrade | Underweight (Neutral) |
N/A (N/A) |
0.31 (0.28) |
-9.68% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||